Literature DB >> 7777182

Female rats are more susceptible to the development of neuropathic pain using the partial sciatic nerve ligation (PSNL) model.

D E Coyle1, C S Sehlhorst, C Mascari.   

Abstract

A comparison study was conducted to determine if a gender difference could be detected using an animal model for causalgia. The sciatic nerve was tightly ligated so that 1/3 to 1/2 of the nerve thickness was trapped by the ligature, just distal to the point at which the posterior biceps semitendinosus nerve branches off the common sciatic nerve. By measuring paw withdrawal from innocuous stimulation with Von Frey filaments, the percent of rats displaying average mechanical sensitivity of the injured paw that was significantly elevated compared to sham or unoperated control animals (days 22-24) was 28.6% for the male group versus 63.6% for the female group. Our animals did not display a consistent response in withdrawal latency to heat applied to the plantar surface of the root (hyperpathia). The data suggests that female rats are significantly more susceptible to developing neuropathic pain than male rats using this experimental model for causalgia.

Entities:  

Mesh:

Year:  1995        PMID: 7777182     DOI: 10.1016/0304-3940(95)11304-f

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

Review 2.  Sex, gender, and pain: an overview of a complex field.

Authors:  Robert W Hurley; Meredith C B Adams
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

3.  Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception.

Authors:  Veronika Khariv; Li Ni; Ayomi Ratnayake; Sujitha Sampath; Brianna M Lutz; Xuan-Xiang Tao; Robert F Heary; Stella Elkabes
Journal:  FASEB J       Date:  2016-10-04       Impact factor: 5.191

4.  The organizational and activational effects of sex hormones on tactile and thermal hypersensitivity following lumbar nerve root injury in male and female rats.

Authors:  Michael L LaCroix-Fralish; Vivianne L Tawfik; Joyce A DeLeo
Journal:  Pain       Date:  2005-03       Impact factor: 6.961

5.  Estrogen effects on pain sensitivity and neuropeptide expression in rat sensory neurons.

Authors:  Susan Sarajari; Monica M Oblinger
Journal:  Exp Neurol       Date:  2010-03-19       Impact factor: 5.330

6.  Behavioral assessment of temporal summation in the rat: sensitivity to sex, opioids and modulation by NMDA receptor antagonists.

Authors:  Lisa M Lomas; Mitchell J Picker
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

Review 7.  Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors.

Authors:  Alan R Gintzler; Nai-Jiang Liu
Journal:  Front Neuroendocrinol       Date:  2012-10-02       Impact factor: 8.606

8.  Studying sex and gender differences in pain and analgesia: a consensus report.

Authors:  Joel D Greenspan; Rebecca M Craft; Linda LeResche; Lars Arendt-Nielsen; Karen J Berkley; Roger B Fillingim; Michael S Gold; Anita Holdcroft; Stefan Lautenbacher; Emeran A Mayer; Jeffrey S Mogil; Anne Z Murphy; Richard J Traub
Journal:  Pain       Date:  2007-10-25       Impact factor: 6.961

9.  Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic.

Authors:  Arjun Kumar; Nai-Jiang Liu; Priyanka A Madia; Alan R Gintzler
Journal:  J Pain       Date:  2015-09-02       Impact factor: 5.820

Review 10.  Sex differences in neuroimmune and glial mechanisms of pain.

Authors:  Ann M Gregus; Ian S Levine; Kelly A Eddinger; Tony L Yaksh; Matthew W Buczynski
Journal:  Pain       Date:  2021-08-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.